SAN JOSE (Reuters) -Intel said on Tuesday several of its contract manufacturing customers planned to build test chips for the company's forthcoming advanced manufacturing process that is currently ...

"As the first U.S. producer of plasma-derived products to achieve regulatory approval for its innovative yield enhancement production process, ADMA continues to demonstrate its leadership in ...

margin expansion and production output capacity as a result of FDA approval of the yield enhancement process, and timing related thereto, and our R&D platform. Actual events or results may differ ...

(RTTNews) - ADMA Biologics, Inc. (ADMA) Monday said that the United States Food and Drug Administration (FDA) has approved the company's innovative production yield enhancement process. The ...

today announced it will present preclinical data on a feeder-free manufacturing process for IL-2-independent TIL expansion at the 28th Annual Meeting of the American Society of Gene and Cell Therapy ...

Dragonfly Energy is also undergoing a strategic shift, focusing on electrode tape production and optimizing corporate operations to improve financial performance. The company anticipates positive ...

TSMC recently unveiled its next generation manufacturing process, A14. The Taiwanese fab made the announcement last week in the US and is set to enter mass production in 2028. The A14 process is ...

The still-in-development manufacturing process known as 14A had planned to introduce a new type of advanced chipmaking tool known as a high-NA EUV machine. The 14A process also includes a new ...

Intel also announced on Tuesday that its highly anticipated 18A (1.8-nanometer) process has entered the risk production phase and is expected to achieve mass production this year. Meanwhile, the ...

This innovative process has demonstrated an ability to increase production yields by approximately 20% from the same starting plasma volume. “This approval represents a pivotal milestone for ADMA, ...